Bristol-Myers Squibb & Co (NYSE:BMY) has returned the exclusive rights to Dragonfly Therapeutics‘ IL-12 oncology candidate. In 2020, BMS handed out $475 million in…
Cboe Digital to become first U.S. regulated crypto native exchange and clearinghouse to enable both spot and leveraged derivatives trading on a single platform11 leading firms across crypto and traditional finance